- Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Suzuki, T., Kiyoi, H., Ozeki, K., Tomita, A., Yamaji, S., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Ueda, R., Kinoshita, T., Emi, N., Naoe, T. Blood (2005)
- Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Piva, R., Chiarle, R., Manazza, A.D., Taulli, R., Simmons, W., Ambrogio, C., D'Escamard, V., Pellegrino, E., Ponzetto, C., Palestro, G., Inghirami, G. Blood (2006)
- Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Cazzaniga, G., Dell'Oro, M.G., Mecucci, C., Giarin, E., Masetti, R., Rossi, V., Locatelli, F., Martelli, M.F., Basso, G., Pession, A., Biondi, A., Falini, B. Blood (2005)
- Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Berger, R., Busson, M., Baranger, L., Hélias, C., Lessard, M., Dastugue, N., Speleman, F. Leukemia (2006)
- Nucleophosmin: A versatile molecule associated with hematological malignancies. Naoe, T., Suzuki, T., Kiyoi, H., Urano, T. Cancer Sci. (2006)
- Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Mullighan, C.G., Kennedy, A., Zhou, X., Radtke, I., Phillips, L.A., Shurtleff, S.A., Downing, J.R. Leukemia (2007)
- Re-evaluating age-of-acquisition effects: are they simply cumulative-frequency effects? Lewis, M.B., Gerhand, S., Ellis, H.D. Cognition. (2001)
- Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Okuda, M., Horn, H.F., Tarapore, P., Tokuyama, Y., Smulian, A.G., Chan, P.K., Knudsen, E.S., Hofmann, I.A., Snyder, J.D., Bove, K.E., Fukasawa, K. Cell (2000)
- Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Wells, R.A., Catzavelos, C., Kamel-Reid, S. Nat. Genet. (1997)
- Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Chiarle, R., Simmons, W.J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J.G., Levy, D.E., Inghirami, G. Nat. Med. (2005)
- Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K., Shapiro, D.N., Look, A.T., Saltman, D.L. Science (1995)
- In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Bocker, T., Bittinger, A., Wieland, W., Buettner, R., Fauser, G., Hofstaedter, F., Rüschoff, J. Mod. Pathol. (1995)
- SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. Honorat, J.F., Ragab, A., Lamant, L., Delsol, G., Ragab-Thomas, J. Blood (2006)
- Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. Skaar, T.C., Prasad, S.C., Sharareh, S., Lippman, M.E., Brünner, N., Clarke, R. J. Steroid Biochem. Mol. Biol. (1998)
- Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. Kasprzycka, M., Marzec, M., Liu, X., Zhang, Q., Wasik, M.A. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Bai, R.Y., Ouyang, T., Miething, C., Morris, S.W., Peschel, C., Duyster, J. Blood (2000)
- Nucleophosmin sets a threshold for p53 response to UV radiation. Maiguel, D.A., Jones, L., Chakravarty, D., Yang, C., Carrier, F. Mol. Cell. Biol. (2004)
- Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., Yamamoto, T. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Cussac, D., Greenland, C., Roche, S., Bai, R.Y., Duyster, J., Morris, S.W., Delsol, G., Allouche, M., Payrastre, B. Blood (2004)
- Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Yee, H.T., Ponzoni, M., Merson, A., Goldstein, M., Scarpa, A., Chilosi, M., Menestrina, F., Pittaluga, S., de Wolf-Peeters, C., Shiota, M., Mori, S., Frizzera, G., Inghirami, G. Blood (1996)
- The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Redner, R.L., Rush, E.A., Faas, S., Rudert, W.A., Corey, S.J. Blood (1996)
- Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin. Bonvini, P., Gastaldi, T., Falini, B., Rosolen, A. Cancer Res. (2002)
- B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1. Zhang, H., Shi, X., Paddon, H., Hampong, M., Dai, W., Pelech, S. J. Biol. Chem. (2004)
- Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation. Liu, H., Tan, B.C., Tseng, K.H., Chuang, C.P., Yeh, C.W., Chen, K.D., Lee, S.C., Yung, B.Y. EMBO Rep. (2007)
- Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. Sato, K., Hayami, R., Wu, W., Nishikawa, T., Nishikawa, H., Okuda, Y., Ogata, H., Fukuda, M., Ohta, T. J. Biol. Chem. (2004)
- The ARF tumour suppressor. Gallagher, S.J., Kefford, R.F., Rizos, H. Int. J. Biochem. Cell Biol. (2006)
- Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Bischof, D., Pulford, K., Mason, D.Y., Morris, S.W. Mol. Cell. Biol. (1997)
- MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia. Xie, J., Briggs, J.A., Morris, S.W., Olson, M.O., Kinney, M.C., Briggs, R.C. Exp. Hematol. (1997)
- Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis. Okada, M., Jang, S.W., Ye, K. J. Biol. Chem. (2007)
- Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR. Pang, Q., Christianson, T.A., Koretsky, T., Carlson, H., David, L., Keeble, W., Faulkner, G.R., Speckhart, A., Bagby, G.C. J. Biol. Chem. (2003)
- The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Okuwaki, M., Tsujimoto, M., Nagata, K. Mol. Biol. Cell (2002)
- Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during natural killer cell-mediated killing. Cullen, S.P., Afonina, I.S., Donadini, R., Lüthi, A.U., Medema, J.P., Bird, P.I., Martin, S.J. J. Biol. Chem. (2009)
- Effects of anti-PM-Scl 100 (Rrp6p exonuclease) antibodies on prenucleolar body dynamics at the end of mitosis. Fomproix, N., Hernandez-Verdun, D. Exp. Cell Res. (1999)
- Nucleophosmin regulates the stability and transcriptional activity of p53. Colombo, E., Marine, J.C., Danovi, D., Falini, B., Pelicci, P.G. Nat. Cell Biol. (2002)
- Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Itahana, K., Bhat, K.P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R., Zhang, Y. Mol. Cell (2003)
- Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Wang, W., Budhu, A., Forgues, M., Wang, X.W. Nat. Cell Biol. (2005)
- A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., Mariamé, B. Blood (1999)
- The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. Haindl, M., Harasim, T., Eick, D., Muller, S. EMBO Rep. (2008)
- Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K.G., Shapiro, D.N., Saltman, D.L., Look, A.T. Science (1994)
- Nucleophosmin gene mutations in acute myeloid leukemia. Chen, W., Rassidakis, G.Z., Medeiros, L.J. Arch. Pathol. Lab. Med. (2006)
- Functional proteomic analysis of melanoma progression. Bernard, K., Litman, E., Fitzpatrick, J.L., Shellman, Y.G., Argast, G., Polvinen, K., Everett, A.D., Fukasawa, K., Norris, D.A., Ahn, N.G., Resing, K.A. Cancer Res. (2003)